期刊文献+

Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis 被引量:19

Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis
下载PDF
导出
摘要 AIM: To investigate the levels of D-dimer(DD) and vonWillebrand factor(vWF) and the relationship between DDand vWF in ulcerative colitis(UC) patients.METHODS: A total of 29 plasma specimens were obtainedfrom patients with ulcerative colitis (male 13, female 16),aged 21-47 years (33 + 11). Disease activity was assessed byTruelove-Writeria. Patients with a score of above 5 wereregarded as having active colitis. Twenty healthy people(male 12, female 8),aged 19-53 years(31 + 14), ssrved asnormal controls. Blood samples were taken from anantecubital vein puncture. Blood(1.8 mL) was injected intothe tubes containing sodium citrate (0. 13 mmol/L). Theplasma was obtained by centrifugation at 3000 r@ min-1 for 10min, and stored at -80 ℃ until assayed by ELISA.RESULTS: The mean plasma levels of DD and vWF in activeUC patients were significantly higher than those of thecontrols(0.69+0.41 vs0.27+0.11, P<0.01;143+46 vs103 + 35, P < 0.01 ). The mean plasma levels of DD in thepatients with active disease were higher than those withinactive disease(0. 69 + 0. 41 vs 0.48+0.29, P<0.05). Thelevls of v WF were not different between active and inactivepatients. DD levels were positively related to vWF levels( r =0.574, P < 0. 01 ). There was no significant differencebetween levels of DD and vWF and the scope of disease cndsex of the patients.CONCLUSION: vWF is an important feature and a goodmarker of UC; intravascular thrombus and endothelial celldysfunction were found in UC patients; and the combinedtest of DD and vWF is helpful to distinguish the activity ofthe UC patients. AIM: To investigate the levels of D-dimer(DD) and von Willebrand factor(vWF) and the relationship between DD and vWF in ulcerative colitis(UC) patients. METHODS: A total of 29 plasma specimens were obtained from patients with ulcerative colitis (male 13, female 16) aged 21-47 years (33+/-11). Disease activity was assessed by Truelove-Writeria. Patients with a score of above 5 were regarded as having active colitis. Twenty healthy people(male 12, female 8) aged 19-53 years(31+/-14) served as normal controls. Blood samples were taken from an antecubital vein puncture. Blood(1.8 mL) was injected into the tubes containing sodium citrate (0.13 mmol/L). The plasma was obtained by centrifugation at 3000 r.min(-1) for 10 min, and stored at -80 degrees until assayed by ELISA. RESULTS: The mean plasma levels of DD and vWF in active UC patients were significantly higher than those of the controls (0.69+/-0.41 vs 0.27+/-0.11, P<0.01 143+/-46 vs 103+/-35, P<0.01). The mean plasma levels of DD in the patients with active disease were higher than those with inactive disease(0.69+/-0.41 vs 0.48+/-0.29 P<0.05). The levels of vWF were not different between active and inactive patients. DD levels were positively related to vWF levels( r =0.574, P<0.01). There was no significant difference between levels of DD and vWF and the scope of disease and sex of the patients. CONCLUSION: vWF is an important feature and a good marker of UC intravascular thrombus and endothelial cell dysfunction were found in UC patients and the combined test of DD and vWF is helpful to distinguish the activity of the UC patients.
作者 XuG TianKL
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第3期575-576,共2页 世界胃肠病学杂志(英文版)
关键词 溃疡性结肠炎 D-二聚物 Von willtbrand 因子 临床意义 Adult Biological Markers Colitis, Ulcerative Female Fibrin Fibrinogen Degradation Products Humans Male Middle Aged von Willebrand Factor
  • 相关文献

参考文献10

  • 1Albomoz L,Alvarez D,Otaso JC,Gadano A,Salviu J,Gerona S,Sorroche P,Villamil A,Mastai R.von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis:relationship to degree of liver failure and nitric oxide levels[].Journal of Hepatology.1999
  • 2Kohno I,Inuzuka K,Itoh Y,Nakahara K,Eguchi Y,Sugo T,Soe G,Sakata Y,Murayama H,Matsuda M.A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin:its application to the measurement of granulocyte-derived elastase digests in plasma[].Blood.2000
  • 3Xu G,Zhong XJ,Guo WM,Sui RL,Tang SL,Sun YP.D-dimer and von Willebrand factor levels in acute pancreatitis patints[].World Chinese Journal of Digestology.1999
  • 4Cui HF,Jiang XL.Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin[J].World Journal of Gastroenterology,1999,5(5):448-450. 被引量:24
  • 5Kiron M. Das,Sherif A. Farag.Current medical therapy of inflammatory bowel disease[J].World Journal of Gastroenterology,2000,6(4):483-489. 被引量:16
  • 6Danesh J,Whincup P,Walker M,Lermon L,Thomson A,Appleby P,Rumley A.Lowe GD: Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis[].Circulation.2001
  • 7Goldsmith I,Kumar P,Carter P,Blann AD,Patel RL,Lip GY.Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study[].American Heart Journal.2000
  • 8Jager A,van-Hinsbergh VW,Kostense PJ,Emesis JJ,Nijpels G,Dekker JM,Heine RJ,Bouter LM,Stehonwer CD.Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes:the Hoorn study[].Diabetes.2000
  • 9Feng,D,Bursell,SE,Clermont,AC.von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes[].Diabetes Care.2000
  • 10Thomas K. Makris MD,George A. Stavroulakis MD,Urania G. Dafni DSc,Argyri E. Gialeraki PhD,Panagiota G. Krespi MD,Antonios N. Hatzizacharias MD,Caterina G. Tsoukala MD,John S. Vythoulkas MD and Michael K. Kyriakidis MDa,d.ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension[].American Heart Journal.2000

二级参考文献71

  • 1Bmuillard M,Gheerbrant JD,Gheysens Y.Interstitial uephritis and mesalazine:three new cases?. Gastro Clinique & Biologique . 1998
  • 2Danielsson A.Treatment of distal ulcerative colitis with nonsystemic corticosteroid enemas. Scandinavian Journal of Gastroenterology . 1996
  • 3Cappell MS,Das KM.Rapid development of pancreatitis fallowiug reuse of 6-mercaptopurine. Journal of Clinical Gastroenterology . 1989
  • 4Francella A,Dayan A,Rubin P.6-mercaptopurine(6-MP)is safe therapy for child bearing patients with inflammatory bowel disease(IBD):A case controlled study. Gastroenterology . 1996
  • 5Griffel LH,Das KM.The smoke is beginning to clear. Inflam Bowel Dis . 1996
  • 6Burke A,Lichtenstein GR,Rombeau JL.Nutrition and ulcerative colitis. Bailliere s Clinical Oncology . 1997
  • 7Cummings JH.Short-chain fatty acid enemas in the treatment of distal ulcerative colitis. European J Gastroenterol Hepatol . 1997
  • 8Bellazzi A,Bridolen C,Campieri M.Effect of enteric-control fish-oil preparation on relapses in Crohn‘s disease. The New England Journal of Medicine . 1996
  • 9Korelitz B,Hanauer S,Rutgeerts P.Post-operative prophylaxis with 6-MP,5-ASA or placebo in Crohn‘s disease:a 2 year multicenter trial. Gastroenterology . 1998
  • 10Das,KM.Sulfasalazine therapy in inflammatory bowel disease. Gastroenterology Clinics of North America . 1989

共引文献36

同被引文献137

引证文献19

二级引证文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部